Identification of transcriptomic determinants to predict the efficacy of anti-EGFR treatment of colorectal cancer patients.

被引：0
|
作者：
Chowdhury, Saikat [1 ]
Shen, John Paul Y. C. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 03期
关键词：
D O I：
10.1200/JCO.2021.39.3_suppl.130
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
130
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Anti-EGFR (cetuximab) combined with irinotecan for treatment of elderly patients with metastatic colorectal cancer (mCRC)
    Abdelwahab, S.
    Azmy, A.
    Abdel-aziz, H.
    Salim, H.
    Mahmoud, A.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (09) : 1487 - 1492
  • [22] MicroRNA-31 May Predict Response in Patients With Metastatic Colorectal Cancer Treated With Anti-EGFR Therapy
    Mitsuhashi, Kei
    Nosho, Katsuhiko
    Igarashi, Hisayoshi
    Ito, Miki
    Naito, Takafumi
    Sukawa, Yasutaka
    Okuda, Hiroyuki
    Yoshii, Shinji
    Kusumi, Takaya
    Hosokawa, Masao
    Yamamoto, Eiichiro
    Suzuki, Hiromu
    Yamamoto, Hiroyuki
    Imai, Kohzoh
    Shinomura, Yasuhisa
    GASTROENTEROLOGY, 2014, 146 (05) : S329 - S330
  • [23] Anti-EGFR Antibodies in the Management of Advanced Colorectal Cancer
    Kasi, Pashtoon Murtaza
    Afable, Manuel Geroy
    Herting, Cameron
    Lukanowski, Mariusz
    Jin, Zhaohui
    ONCOLOGIST, 2023, : 1034 - 1048
  • [24] Mechanisms of resistance to anti-EGFR therapy in colorectal cancer
    Zhao, Ben
    Wang, Lu
    Qiu, Hong
    Zhang, Mingsheng
    Sun, Li
    Peng, Ping
    Yu, Qianqian
    Yuan, Xianglin
    ONCOTARGET, 2017, 8 (03) : 3980 - 4000
  • [25] Markers of resistance to anti-EGFR therapy in colorectal cancer
    Shaib, Walid
    Mahajan, Reena
    El-Rayes, Bassel
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2013, 4 (03) : 308 - 318
  • [26] Mechanisms of resistance to anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer
    Zacharenia Saridaki
    Vassilis Georgoulias
    John Souglakos
    World Journal of Gastroenterology, 2010, 16 (10) : 1177 - 1187
  • [27] Adverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancer
    Fakih, M.
    Vincent, M.
    CURRENT ONCOLOGY, 2010, 17 : S18 - S30
  • [28] Integrating anti-EGFR therapies in metastatic colorectal cancer
    Haraldsdottir, Sigurdis
    Bekaii-Saab, Tanios
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2013, 4 (03) : 285 - 298
  • [29] Mechanisms of resistance to anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer
    Saridaki, Zacharenia
    Georgoulias, Vassilis
    Souglakos, John
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (10) : 1177 - 1187
  • [30] KRAS mutation testing in the treatment of metastatic colorectal cancer with anti-EGFR therapies
    Soulieres, D.
    Greer, W.
    Magliocco, Anthony M.
    Huntsman, D.
    Young, S.
    Tsao, M-S.
    Kamel-Reid, S.
    CURRENT ONCOLOGY, 2010, 17 : S31 - S40
12345